Hanne M.
- Country
- Belgium
- Department
- Hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 29 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating acute myeloid leukemia (AML), with particular focus on developing therapeutic strategies for patients with refractory and relapsed conditions.
- Advanced Leukemia Treatment
- Combination Therapy Approaches
- Second-line Treatment Strategies
Their research encompasses innovative combination therapies aimed at improving remission rates in challenging AML cases.
Treatment Innovation
The investigator focuses on evaluating novel therapeutic combinations, particularly exploring the potential of L-Annamycin in conjunction with established treatments for hematologic malignancies.
- Drug Optimization Studies
- Remission Induction Protocols
- Treatment Response Assessment
Their work involves determining optimal dosing regimens for enhanced therapeutic outcomes in resistant disease states.
Clinical Research Methodology
The investigator's expertise extends to conducting multi-center clinical studies focused on comparing novel therapeutic approaches against standard treatments.
- Comparative Treatment Analysis
- Clinical Response Evaluation
- Adult Patient Population Studies
Their research methodology emphasizes rigorous assessment of treatment efficacy in challenging hematologic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.